EtiraRX
EtiraRX is a startup headquartered in Dallas, United States, founded in 2021. It has raised at least $9.5m in outside funding, according to its filings with the US Securities and Exchange Commission (Form D), which puts it at the early stage.
Part of the 311 Institute Global Startups Directory (311institute.com). Last updated .
Funding
EtiraRX has raised at least $9.5m in outside funding, according to its Form D filings with the US Securities and Exchange Commission. Form D figures are a minimum: not every round is filed.
R&D ecosystem
EtiraRX sits inside the Dallas R&D ecosystem in the Global R&D Labs Directory.
Other startups in Dallas
- 4mindsai
- ACTion Battery Technologies
- AVID Group
- Cariloop
- Cessation Therapeutics
- Colors4kids (01-45)
- Colossal Biosciences
- Conflixis
- Curiosities
- DataBahn
- GenrAb
Related
- Innovation profile of Dallas
- United States: economy and key statistics
- Global Investors Directory
- All 311 Indexes
Questions and answers
What does EtiraRX do?
EtiraRX is classed in biotechnology in its filings with the US Securities and Exchange Commission.
How much has EtiraRX raised?
At least $9.5m, according to its Form D filings with the US Securities and Exchange Commission.
Where is EtiraRX based?
EtiraRX is headquartered in Dallas, United States.
When was EtiraRX founded?
EtiraRX was founded in 2021.
Source record: SEC EDGAR (Form D filings).
© 311 Institute 2026. Facts from the official sources linked on this page. The selection, classification and links are the proprietary work of the 311 Institute, protected by copyright and database rights.